230 related articles for article (PubMed ID: 8494898)
1. Role of native disulfide bonds in the structure and activity of insulin-like growth factor 1: genetic models of protein-folding intermediates.
Narhi LO; Hua QX; Arakawa T; Fox GM; Tsai L; Rosenfeld R; Holst P; Miller JA; Weiss MA
Biochemistry; 1993 May; 32(19):5214-21. PubMed ID: 8494898
[TBL] [Abstract][Full Text] [Related]
2. Disulfide exchange folding of disulfide mutants of insulin-like growth factor I in vitro.
Hober S; Uhlén M; Nilsson B
Biochemistry; 1997 Apr; 36(15):4616-22. PubMed ID: 9109671
[TBL] [Abstract][Full Text] [Related]
3. Oxidative refolding of insulin-like growth factor 1 yields two products of similar thermodynamic stability: a bifurcating protein-folding pathway.
Miller JA; Narhi LO; Hua QX; Rosenfeld R; Arakawa T; Rohde M; Prestrelski S; Lauren S; Stoney KS; Tsai L
Biochemistry; 1993 May; 32(19):5203-13. PubMed ID: 8494897
[TBL] [Abstract][Full Text] [Related]
4. The different energetic state of the intra A-chain/domain disulfide of insulin and insulin-like growth factor 1 is mainly controlled by their B-chain/domain.
Guo ZY; Shen L; Feng YM
Biochemistry; 2002 Aug; 41(34):10585-92. PubMed ID: 12186542
[TBL] [Abstract][Full Text] [Related]
5. The folding nucleus of the insulin superfamily: a flexible peptide model foreshadows the native state.
Hua QX; Mayer JP; Jia W; Zhang J; Weiss MA
J Biol Chem; 2006 Sep; 281(38):28131-42. PubMed ID: 16864583
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the B-domain of insulin-like growth factor-I influence the oxidative folding to yield products with modified biological properties.
Milner SJ; Francis GL; Wallace JC; Magee BA; Ballard FJ
Biochem J; 1995 Jun; 308 ( Pt 3)(Pt 3):865-71. PubMed ID: 8948444
[TBL] [Abstract][Full Text] [Related]
7. Probing the disulfide folding pathway of insulin-like growth factor-I.
Milner SJ; Carver JA; Ballard FJ; Francis GL
Biotechnol Bioeng; 1999 Mar; 62(6):693-703. PubMed ID: 9951525
[TBL] [Abstract][Full Text] [Related]
8. A protein caught in a kinetic trap: structures and stabilities of insulin disulfide isomers.
Hua QX; Jia W; Frank BH; Phillips NF; Weiss MA
Biochemistry; 2002 Dec; 41(50):14700-15. PubMed ID: 12475219
[TBL] [Abstract][Full Text] [Related]
9. Hierarchical protein folding: asymmetric unfolding of an insulin analogue lacking the A7-B7 interchain disulfide bridge.
Hua QX; Nakagawa SH; Jia W; Hu SQ; Chu YC; Katsoyannis PG; Weiss MA
Biochemistry; 2001 Oct; 40(41):12299-311. PubMed ID: 11591149
[TBL] [Abstract][Full Text] [Related]
10. The different folding behavior of insulin and insulin-like growth factor 1 is mainly controlled by their B-chain/domain.
Guo ZY; Shen L; Feng YM
Biochemistry; 2002 Feb; 41(5):1556-67. PubMed ID: 11814349
[TBL] [Abstract][Full Text] [Related]
11. Disulfide exchange folding of insulin-like growth factor I.
Hober S; Forsberg G; Palm G; Hartmanis M; Nilsson B
Biochemistry; 1992 Feb; 31(6):1749-56. PubMed ID: 1737028
[TBL] [Abstract][Full Text] [Related]
12. Native and non-native structure in a protein-folding intermediate: spectroscopic studies of partially reduced IGF-I and an engineered alanine model.
Hua QX; Narhi L; Jia W; Arakawa T; Rosenfeld R; Hawkins N; Miller JA; Weiss MA
J Mol Biol; 1996 Jun; 259(2):297-313. PubMed ID: 8656430
[TBL] [Abstract][Full Text] [Related]
13. Refolding of amphioxus insulin-like peptide: implications of a bifurcating evolution of the different folding behavior of insulin and insulin-like growth factor 1.
Wang S; Guo ZY; Shen L; Zhang YJ; Feng YM
Biochemistry; 2003 Aug; 42(32):9687-93. PubMed ID: 12911310
[TBL] [Abstract][Full Text] [Related]
14. Local structural preferences in the alpha-lactalbumin molten globule.
Peng ZY; Wu LC; Kim PS
Biochemistry; 1995 Mar; 34(10):3248-52. PubMed ID: 7880819
[TBL] [Abstract][Full Text] [Related]
15. Putative disulfide-forming pathway of porcine insulin precursor during its refolding in vitro.
Qiao ZS; Guo ZY; Feng YM
Biochemistry; 2001 Mar; 40(9):2662-8. PubMed ID: 11258877
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factors I and II are unable to form and maintain their native disulfides under in vivo redox conditions.
Hober S; Lundström Ljung J; Uhlén M; Nilsson B
FEBS Lett; 1999 Jan; 443(3):271-6. PubMed ID: 10025946
[TBL] [Abstract][Full Text] [Related]
17. Mutation of Arg55/56 to Leu55/Ala56 in insulin-like growth factor-I results in two forms different in disulfide structure and native conformation but similar under reverse-phase conditions.
Rosenfeld RD; Noone NM; Lauren SL; Rohde MF; Narhi LO; Arakawa T
J Protein Chem; 1993 Jun; 12(3):247-54. PubMed ID: 8397784
[TBL] [Abstract][Full Text] [Related]
18. "Designing out" disulfide bonds: thermodynamic properties of 30-51 cystine substitution mutants of bovine pancreatic trypsin inhibitor.
Liu Y; Breslauer K; Anderson S
Biochemistry; 1997 May; 36(18):5323-35. PubMed ID: 9154914
[TBL] [Abstract][Full Text] [Related]
19. Folding of insulin-like growth factor I is thermodynamically controlled by insulin-like growth factor binding protein.
Hober S; Hansson A; Uhlén M; Nilsson B
Biochemistry; 1994 Jun; 33(22):6758-61. PubMed ID: 7515683
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional solution structure of a disulfide bond isomer of the human insulin-like growth factor-I.
Sato A; Koyama S; Yamada H; Suzuki S; Tamura K; Kobayashi M; Niwa M; Yasuda T; Kyogoku Y; Kobayashi Y
J Pept Res; 2000 Oct; 56(4):218-30. PubMed ID: 11083061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
